API: Carfilzomib/Bortezomib/Thiotepa/Ferric Carboxymaltose/Goserelin acetate/Ixazomib citrate

  • API: Carfilzomib/Bortezomib/Thiotepa/Ferric Carboxymaltose/Goserelin acetate/Ixazomib citrate 1
  • API: Carfilzomib/Bortezomib/Thiotepa/Ferric Carboxymaltose/Goserelin acetate/Ixazomib citrate 2
Product Description

——1. Carfilzomib: commercial API, DMF available, W.C. to be available in April 2024 2024)——Bortezomib: commercial API, DMF available, W.C. to be available in April 2024
——2. Thiotepa: 
Commercial API, DMF available, W.C. to be available in April 2024
——3. Ferric carboxymaltose: 
commercial API, DMF to be available in Q2 2024. W.C. to be available in Aprill
——4. Calcium Levofolinate: 
commercial API, DMF available
——5. Ixazomib citrate: 
commercial API, DMF in Q3 2024

Read more Show less

Sichuan Huiyu Pharmaceutical Co.,Ltd.

  • CN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less
Specifications
  • CAS Registry Number
    868540-17-4
  • Details
    EP/USP/CP/JP/IN-HOUSE
  • Selling Points
    International Approvals/Standards; Price; Small Orders Accepted
  • Model
    Customized
  • Supplied from
    China
  • Measured In
    kilogram
More specifications Fewer specifications
Sales Markets
Show more Show less

Sichuan Huiyu Pharmaceutical Co.,Ltd.

  • CN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Pharmaceutical Company (generic finished products)
View company profile

More Products from Sichuan Huiyu Pharmaceutical Co.,Ltd. (4)

  • Azacitidine Seacross 25mg/ml Powder for suspension for injection

    Product Azacitidine Seacross 25mg/ml Powder for suspension for injection

    Therapeutic indications:Azacitidine Seacross is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (HSCT) with:

    •intermediate-2 and high-risk myelodysplastic syndromes (MDS) according to the International Prognostic Scoring System ...
  • Zoledronic Acid Seacross 5mg/100ml solution for infusion

    Product Zoledronic Acid Seacross 5mg/100ml solution for infusion

    Therapeutic indications:  
    Treatment of osteoporosis：•in post-menopausal women•in adult men at increased risk of fracture, including those with a recent low-trauma hip fracture.Treatment of osteoporosis associated with long-term systemic glucocorticoid therapy： •in post-menopausal wo...
  • Docetaxel 20 mg/ml Concentrate for solution for infusion

    Product Docetaxel 20 mg/ml Concentrate for solution for infusion

    Therapeutic indications:Breast cancer, sarcoma, small-cell carcinoma of the lung, Hodgkin disease or non-Hodgkin lymphoma, acute leukaemia, cancer of the thyroid, bladder, ovaries, Paediatric tumours, such as neuroblastoma. Doxorubicin is frequently used in combination chemotherapy regimens with other...
  • Paclitaxel 6 mg/ml concentrate for solution for infusion

    Product Paclitaxel 6 mg/ml concentrate for solution for infusion

    Paclitaxel Injection is used to treat:

    Ovarian cancer:

    • as first therapy (after initial surgery in combination with the platinum-containing medicine cisplatin).

    • after standard platinum-containing medicines have been tried but did not work.
    ...